Get Funding & Stay on Path to a Successful Exit

Our dedicated team of experts understand life science startups and scale-ups. We partner with innovative R&D-driven, founder-led teams to help them gain traction, reach milestones, and scale.

We support our innovators with custom-fit services — regardless of their current growth stage. From core accounting and biz-ops functions to fractional CFO services – as your company reaches milestones and attains success, our solutions evolve to meet your growing and emerging needs.

From pre-seed startup or grant stage, through funding rounds, scale-up & exit – we’re your partner in growth!


Fund & Scale, Faster & Smarter

  • Grant Accounting & Compliance (SBIR+)
  • Startup Accounting Packages
  • Positioning for Capital – Due Dil. Prep & Support
  • Investor-Ready Proformas
  • Cashflow & Scale-up Planning
  • Accounting, Payroll & HR Lite Support
  • Fractional CFO Strategy
  • R&D Tax Credits (Incl. pre-revenue!)
  • Cap Table Integration
  • Board & Investor Reporting
  • Board & Investor Communications
  • Tax Planning & Prep
  • Real-time KPI Dashboards
  • Audit Prep & Management
  • GovCon Accounting (DCAA compliance)
  • Exit Prep & Support
GET STARTED


Client Testimonials
Life Science & Healthcare

I WANT TO GROW TOO


De-Risk Your Life Sciences Venture
& Stretch Your Runway

Grant accounting for med tech life science startups
Companies in your sector — whether therapeutics, diagnostics,  medical device, or digital health — call on us because they know we have the expertise to help them reach their potential.
We engage with a stakeholder mindset – streamlining BizOps, shortening the path to capital, and navigating the scale-up ceilings that could jeopardize your dream.
Bringing an innovative life science solution to market is risky enough. Plugging in everything — from startup to CPA/CFO guidance in one elegant step — will lighten your burden and speed your journey to success!

HOW CAN WE HELP YOU?

    Ania Camplin
    CPA & Partner

    James Graham, Founder & CEO of Richtr Financial Studio

    James Graham
    CEO & Founder, CPA, CGMA

    Maileen Flores, CPA & Partner at Richtr Financial Studio

    Maileen Flores
    CPA & Partner – Life Science

    Affiliations

    richtr financial studio logo left
    richtr financial studio logo right

    Innovative Biopharma Venture Taps

    Richtr’s Grant Management, Investor Strategy Depth

    Background

    SiVEC Biotechnologies is biotech company based in Fort Collins, CO at the Research Innovation Center.

     

    SiVEC has developed BactPac™, a live biotherapeutic delivery platform to enable the next generation of nucleic acid and gene editing therapies for both human and animal health. The company’s mission is to use the BactPac™ drug delivery platform to develop first-in-class therapeutics and out-license the platform to pharma companies who need a safe, tissue-targeted method of delivery to advance nucleic acid and gene therapies into clinical stages.

     

    SiVEC has been recently recognized as the 2022 Top Emerging Company by the Biotechnology International Organization (BIO) and has been awarded nearly $4 million in grant funds from federal and state agencies.

     

    The collaborative spirit and diversity in scientific expertise of their team was ripe for supplementation by financial rigor and creativity — to secure current sources of funding and additionally define and execute a clear strategy to attract investors and global licensing partners.

    Challenges

    richtr financial studio logo left

    Specialized grant accounting needs
    richtr financial studio logo left

    Company outgrowing simple accounting functions
    richtr financial studio logo left

    Needed fundraising guidance for next growth stage

    Solution

    richtr financial studio logo left

    Quickly fill in accounting ops functions
    richtr financial studio logo left

    Organize and de-risk grant accounting
    richtr financial studio logo left

    Focus and organize fundraising strategy

    Results

    richtr financial studio logo left

    Reduced exposure
    richtr financial studio logo left

    Tax savings
    richtr financial studio logo left

    Pro-forma ready for investor scrutiny

    Challenges

    SiVEC had parlayed its grants, research and intellectual property into a promising biopharma position. Its innovations could make drugs and vaccines across the world more effective.

    But they wanted focused expertise in grant accounting, support in financial ops, and guidance in telling their best story to investors so they could take the venture to the next level. Forecasting ability was limited and the path ahead needed illumination.

    Solution

    Richtr Financial Studio called upon both internal experts and its SME network to ensure SiVEC’s grant accounting was compliant with all legal requirements — also taking over day-to-day accounting functions when another vendor stepped down.

    Then intense collaboration began on forecasting, investment, and licensing strategy — Richtr’s knowledge of biotech and relationships with investors accelerated SiVEC’s ability to understand its fundraising targets, build a plan, and get into capital-raising mode.

    Results

    Richtr administers SiVEC’s grant accounting to this day, yielding tax savings while ensuring compliance. Richtr’s knowledge and connections helped remove obstacles to new international partnerships.

    Both teams are collaborating on a new pro forma as Richtr helps SiVEC get in front of the right investors — with the right questions answered in the numbers.

    Learn more about SiVEC Biotechnologies

    LEARN MORE